Nuvectis Pharma, Inc. (NVCT)
NASDAQ·Healthcare·Biotechnology
$12.56
+5.19%
Mkt Cap $240.54M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
-20.4%
Consensus $10.00 vs current $12.56
NASDAQ·Healthcare·Biotechnology
$12.56
+5.19%
Mkt Cap $240.54M
No recent rating data.
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
-20.4%
Consensus $10.00 vs current $12.56